EpiBesançon 2022 10&11 May

6th edition of EpiCongress

EpiBesançon 2022  is the 6th edition of international epigenetics congress. This meeting is co-organized by the Niches and Epigenetics of Tumors Network of Canceropole Grand Ouest and the epignetics group of INSERM UMR1098. 

This congress is an opportunity for international researchers, PhD students, MD and private industrials to discuss about the development of epigenetic drugs through a better understanding of molecular mechanisms of epigenetics mainly in the field of cancer. Thus, communications will be performed with the goal to inform scientific community about recent and innovative researches in epigenetics in fundamental field and also in medicine/clinical applications.

Thus, we expect that this meeting would open the way to new epigenetic projects and promote new collaborations for your future research. After the virtual meeting that have been held in 2021 we are very happy to warmly welcome you in Besançon in May 2022.

Registration is open here ! Click here to register

Then go to Abstract Submission Guidlines if you want to submit a communication! (deadline 15st April 2022)

Keynote speaker

Mathieu Lupien,  Cancer-associated chromatin variants call attention to repetitive DNA sequences,Toronto, Canada 


Anaïs Bardet, Interplay between transcription factors and DNA methylation in cancer, Strasbourg, France

Rachel Deplus, RNA modifications in cancer, Bruxelles, France

Jérôme Eeckhoute, Control of cellular identity in liver pathophysiology, Lille, France

Francesco Fazi, Non-coding RNA and N6-Methyladenosine (m6A) -dependent networks in cancer cell behavior, Roma Italy

Ciro Isidoro, Non-coding RNA epigenetic regulation of autophagy in cancer, Novara, Italy

Carmen JeronimoNon-coding RNAs in liquid biopsy as prostate cancer biomarkers, Porto, Portugal

Olivier Joffre, Epigenetic control of T helper cell programming, Toulouse, France

Hisham Mohammed, Transcriptional and epigenetic cell states and it’s impact on disease progression in breast cancer,  Portland, USA

Marek Mraz, Impact of microenvionmental interactions on the biology of B cells malignancies, Brno, Czech Republic

Peter Mulligan, Regulation of cancer hallmarks by epigenetic reader proteins, Lyon, France 

Duncan Odom,  How unrepaired DNA lesions shape genome evolutionHeidelberg, Germany

Gilles Salbert, Epigenetic reprogramming of cancer cells, Rennes, France

Petr Svoboda, Small RNA-mediated innate and acquired genome immunity in rodents, Prague, Czech Republic

Céline Vallot, Dynamics of repressive epigenomes in cancer in response to treatment, Paris, France

Elina ZuevaTransposon-host interaction in immune cells, Paris, France